Allergy/Imm

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.

Related Articles

Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09    Relevance Score: 66%

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09    Relevance Score: 64%

Prevalence and distribution of solitary oral pigmented lesions: a prospective study
Journal of the European Academy of Dermatology and Venereology, 10/27/09    Relevance Score: 63%

Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus
Clinical and Experimental Dermatology, 10/08/09    Relevance Score: 63%

Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09    Relevance Score: 47%

Today in Rheumatic/Autoimmune...keeping you current

The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF-[beta]-dependent mechanism
Journal of Leukocyte Biology, 12/15/09

Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven
Journal of Immunology, 12/15/09

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature
Seminars in Arthritis and Rheumatism, 12/15/09